Invention Grant
US08975038B2 Method for determining presence of carcinomic cells with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
有权
用5,10,15,20-四（羧基苯基）卟吩确定癌细胞存在的方法
- Patent Title: Method for determining presence of carcinomic cells with 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
- Patent Title (中): 用5,10,15,20-四（羧基苯基）卟吩确定癌细胞存在的方法
-
Application No.: US13943476Application Date: 2013-07-16
-
Publication No.: US08975038B2Publication Date: 2015-03-10
- Inventor: Jeffrey Garwin
- Applicant: Biomoda, Inc.
- Applicant Address: US TX San Antonio
- Assignee: bioAffinity Technologies, Inc.
- Current Assignee: bioAffinity Technologies, Inc.
- Current Assignee Address: US TX San Antonio
- Agency: Peacock Myers, P.C.
- Agent Janeen Vilven
- Main IPC: G01N33/574
- IPC: G01N33/574
Abstract:
Presented is a method of determining the presence of carcinomic cells in a sample by contacting a sample of cells with a solution of TCPP to permit binding of the TCPP to components of the abnormal dysplastic or carcinomic cells, if any are present; detecting TCPP fluorescence in the sample, the presence of TCPP fluorescence being indicative that the sample contains dysplastic or carcinomic cells.
Public/Granted literature
- US20140162287A1 Method for Prognosing Response to Cancer Therapy with 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine Public/Granted day:2014-06-12
Information query
IPC分类:
